Determination of the functional status of alloreactive T cells by interferon-γ kinetics

Transplantation

Volumn 81, Issue 4, 2006, Pages 590-598

  Kwun, Jean ^a,b   Knechtle, Stuart J ^a   Hu, Huaizhong ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Alloreactivity; Interferon ; Mixed lymphocyte reaction; Mouse

Indexed keywords

ABATACEPT; ALLOANTIGEN; BASILIXIMAB; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; GAMMA INTERFERON; PC 61;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DONOR; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; ISOGRAFT; KINETICS; LYMPHOCYTE FUNCTION; MALE; MEASUREMENT; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SKIN TRANSPLANTATION; SPLEEN CELL; SUPERNATANT; T LYMPHOCYTE; TREATMENT RESPONSE;

ANIMALS; CYCLOSPORINE; GRAFT SURVIVAL; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644615210     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000196353.04494.14     Document Type: Article

References (36)

1. Opferman JT, Ober BT, Ashton-Rickardt PG. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 1999; 283: 1745-1748.
2. Chalasani G, Dai Z, Konieczny BT, et al. Recall and propagation of allospecitic memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 2002; 99: 6175-6180.
3. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
4. Deacock SJ, Lechler RI. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 1992; 54: 338-343.
5. van Besouw NM, van der Mast BJ, de Kuiper P, et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000; 70: 136-143.
6. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701-1702.
7. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502-1510.
8. Buhler LH, Spitzer TR, Sykes M, et al. Induction of kidney allograft tolerance affer transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002; 74: 1405-1409.
9. Knechtle SJ. Clinical trials: where are we now? Immunol Rev 2003; 196: 237-246.
10. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
11. Cartwright NH, Demaine AG, Hurlock NJ, et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol 2000; 8: 109-114.
12. Goldsby RA, Kindt TJ, Osborne BA. B-Cell Generation, Activation and Differentiation. Kuby Immunology. New York: W.H. Freeman and Company, 2000: 269-300.
13. Hu H, Dong Y, Feng P, et al. Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation 2003; 75: 1075-1077.
14. Bell EB, Sparshott SM, Bunce C. CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol Today 1998; 19: 60-64.
15. Selin LK, Vergilis K, Welsh RM, Nahill SR. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 1996; 183: 2489-2499.
16. Yeaman GR, Collins JE, Currie JK, et al. IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol 1998; 160: 5145-5153.
17. Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci U S A 1997; 94: 3948-3953.
18. Wang D, Yuan R, Feng Y, et al. Regulation of CD103 expression by CD8+ T cells responding to renal allografts. J Immunol 2004; 172: 214-221.
19. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94: 8789-8794.
20. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
21. Trambley J, Bingaman AW, Lin A, et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715-1722.
22. Guo Z, Meng L, Kim O, et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 1351-1354.
23. Jones TR, Ha J, Williams MA, et al. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. J Immunol 2002; 168: 1123-1130.
24. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252-259.
25. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
26. Turgeon NA, Iwakoshi NN, Phillips NE, et al. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade. J Surg Res 2000; 93: 63-69.
27. Williams MA, Tan JT, Adams AB, et al. Characterization of virus-mediated inhibition of mixed chimerism and allospecitic tolerance. J Immunol 2001; 167: 4987-4995.
28. Pantenburg B, Heinzel F, Das L, Heeger PS, Valujskikh A. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 2002; 169: 3686-3693.
29. Brehm MA, Markees TG, Daniels KA, et al. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003; 170: 4077-4086.
30. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003; 14: 2402-2410.
31. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
32. Weninger W, Crowley MA, Manjunath N, Von Andrian UH. Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001; 194: 953-966.
33. Iezzi G, Scheidegger D, Lanzavecchia A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med 2001; 193: 987-993.
34. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
35. Reinhardt RL, Khoruts A, Merica R, et al. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001; 410: 101-105.
36. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413-2417.